Mike Maltais, Staff writer
OLYMPIA – When Washington entered tiers 3 and 4 of its Phase 1B COVID vaccine timeline last Wednesday, March 24, it expanded vaccination eligibility to another two million residents including those 16 years or older “with two or more co-morbidities or underlying conditions” a Department of Health bulletin released April 1 said.
A comorbidity is defined as two or more disorders or illnesses occurring in the same person.
Starting April 15, anyone 16 and older wanting a COVID-19 shot will be eligible to receive the Pfizer-BioNTech, the only COVID-19 vaccine authorized for people over 16 years of age. Moderna and Johnson & Johnson are authorized for people 18 and older.
“The state’s phased eligibility approach has helped ensure those most vulnerable were the first to be vaccinated, including older adults, those in long term care facilities, critical health care workers, and more.
Increased vaccine allocations from the federal government have allowed the state to open eligibility sooner than expected. The DOH release said that rising vaccine allocation, subject to change, looks like this for the first three weeks of April:
Week of April 4: 458,340 total doses (285,320 first doses, 173,020 second doses). This includes 201,240 doses of Pfizer, 148,100 doses of Moderna, and 109,000 doses of Johnson & Johnson.
Week of April 11: 412,570 total doses (217,320 first doses, 195,250 second doses). This includes 223,470 doses of Pfizer, 148,100 doses of Moderna, and 41,000 doses of Johnson & Johnson.
Week of April 18: 390,340 total doses (217,320 first doses, 173,020 second doses). This includes 201,240 doses of Pfizer, 148,100 doses of Moderna, and 41,000 doses of Johnson & Johnson.
Comments
No comments on this item Please log in to comment by clicking here